A general process for the development of peptide-based immunoassays for monoclonal antibodies
✍ Scribed by Ana B. Sanchez; Tammy Nguyen; Rhanika Dema-Ala; Andrew C. Kummel; Thomas J. Kipps; Bradley T. Messmer
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 316 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Cervical dystonia (CD) is due to neck‐muscle spasms that cause pain and involuntary contractions resulting in abnormal neck movements and posture. Symptoms can be relieved by injecting the affected muscle with a botulinum neurotoxin (BoNT, usually type A or type B). The therapeutic bene
## Abstract Spleen cells from mice hyperimmunized with a keyhole limpet hemocyanin‐tetrodotoxin‐formaldehyde conjugate were fused with murine P3X63Ag8.653 myeloma cells. A single hybridoma clone was identified that secretes an IgG~1~,k monoclonal antibody (MAb), designated T20G10, against tetrodoto
## Abstract Detection of hepatitis C virus (HCV) antibodies is partially influenced by the genotype of the infecting isolate. Immunoassays using genotype‐1a‐derived recombinants or peptides results in diminished reactivity among individuals infected with heterologous genotypes. We examined the magn
## Abstract High throughput assays for anti‐SARS‐CoV IgG antibody detection are need for large‐scale epidemiologic studies. The performance of a microplate enzyme immunoassay, DETECT‐SARS™, was evaluated for the detection of anti‐SARS‐CoV IgG antibody. This assay is based on synthetic peptides deri